HEADER TRANSCRIPTION 27-JAN-21 7E0A TITLE X-RAY STRUCTURE OF HUMAN PPARGAMMA LIGAND BINDING DOMAIN-SAROGLITAZAR TITLE 2 CO-CRYSTALS OBTAINED BY CO-CRYSTALLIZATION COMPND MOL_ID: 1; COMPND 2 MOLECULE: ISOFORM 2 OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR COMPND 3 GAMMA; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: PPAR-GAMMA,NUCLEAR RECEPTOR SUBFAMILY 1 GROUP C MEMBER 3; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PPARG, NR1C3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS NUCLEAR RECEPTOR, PROTEIN-LIGAND COMPLEX, PPAR, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR S.KAMATA,A.HONDA,K.UCHII,Y.MACHIDA,T.OYAMA,I.ISHII REVDAT 3 29-NOV-23 7E0A 1 REMARK REVDAT 2 22-SEP-21 7E0A 1 JRNL REVDAT 1 08-SEP-21 7E0A 0 JRNL AUTH A.HONDA,S.KAMATA,C.SATTA,Y.MACHIDA,K.UCHII,K.TERASAWA, JRNL AUTH 2 A.NEMOTO,T.OYAMA,I.ISHII JRNL TITL STRUCTURAL BASIS FOR ANTI-NON-ALCOHOLIC FATTY LIVER DISEASE JRNL TITL 2 AND DIABETIC DYSLIPIDEMIA DRUG SAROGLITAZAR AS A PPAR ALPHA JRNL TITL 3 / GAMMA DUAL AGONIST. JRNL REF BIOL.PHARM.BULL. V. 44 1210 2021 JRNL REFN ISSN 0918-6158 JRNL PMID 34471049 JRNL DOI 10.1248/BPB.B21-00232 REMARK 2 REMARK 2 RESOLUTION. 1.77 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.11.1-2575-000 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.77 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.20 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.910 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 34250 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.197 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.221 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3176 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 32.1980 - 5.0313 1.00 2638 142 0.1841 0.1820 REMARK 3 2 5.0313 - 3.9959 1.00 2635 142 0.1534 0.1505 REMARK 3 3 3.9959 - 3.4915 1.00 2674 122 0.1756 0.1814 REMARK 3 4 3.4915 - 3.1726 1.00 2637 133 0.1909 0.2340 REMARK 3 5 3.1726 - 2.9453 1.00 2659 120 0.2090 0.2781 REMARK 3 6 2.9453 - 2.7718 1.00 2628 152 0.2116 0.2415 REMARK 3 7 2.7718 - 2.6330 1.00 2629 120 0.2137 0.2457 REMARK 3 8 2.6330 - 2.5185 1.00 2657 142 0.2071 0.2314 REMARK 3 9 2.5185 - 2.4215 1.00 2642 131 0.2047 0.1926 REMARK 3 10 2.4215 - 2.3380 1.00 2596 143 0.2021 0.2488 REMARK 3 11 2.3380 - 2.2649 1.00 2618 150 0.1944 0.2228 REMARK 3 12 2.2649 - 2.2002 1.00 2665 126 0.1960 0.2054 REMARK 3 13 2.2002 - 2.1423 1.00 2657 144 0.1868 0.2556 REMARK 3 14 2.1423 - 2.0900 1.00 2590 165 0.2043 0.2314 REMARK 3 15 2.0900 - 2.0425 1.00 2625 132 0.2050 0.2567 REMARK 3 16 2.0425 - 1.9991 0.99 2610 157 0.2087 0.2663 REMARK 3 17 1.9991 - 1.9591 0.99 2623 116 0.2201 0.2722 REMARK 3 18 1.9591 - 1.9221 0.99 2655 137 0.2240 0.2844 REMARK 3 19 1.9221 - 1.8878 0.99 2557 150 0.2357 0.2627 REMARK 3 20 1.8878 - 1.8558 0.98 2651 108 0.2369 0.3381 REMARK 3 21 1.8558 - 1.8259 0.99 2584 153 0.2530 0.2901 REMARK 3 22 1.8259 - 1.7978 0.99 2616 150 0.2630 0.3478 REMARK 3 23 1.7978 - 1.7713 0.97 2545 141 0.3038 0.3738 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.220 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.500 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.69 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.17 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.010 2273 REMARK 3 ANGLE : 1.034 3080 REMARK 3 CHIRALITY : 0.060 352 REMARK 3 PLANARITY : 0.006 397 REMARK 3 DIHEDRAL : 17.660 1393 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7E0A COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 28-JAN-21. REMARK 100 THE DEPOSITION ID IS D_1300020456. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-DEC-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-17A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34460 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.770 REMARK 200 RESOLUTION RANGE LOW (A) : 46.530 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 10.80 REMARK 200 R MERGE (I) : 0.06200 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 23.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.77 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.81 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.1 REMARK 200 DATA REDUNDANCY IN SHELL : 8.70 REMARK 200 R MERGE FOR SHELL (I) : 0.30800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 6.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 7AWC REMARK 200 REMARK 200 REMARK: THE ENTRY CONTAINS FRIEDEL PAIRS IN I/F_PLUS/MINUS REMARK 200 COLUMNS. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.84 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.61 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS (PH 8.5), 1.2 M AMMONIUM REMARK 280 SULFATE, 0.1 M MAGNESIUM CHLORIDE HEXAHYDRATE, VAPOR DIFFUSION, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 78.38250 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 32.89900 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 32.89900 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 117.57375 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 32.89900 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 32.89900 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 39.19125 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 32.89900 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 32.89900 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 117.57375 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 32.89900 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 32.89900 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 39.19125 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 78.38250 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 198 REMARK 465 SER A 199 REMARK 465 HIS A 200 REMARK 465 MET A 201 REMARK 465 ILE A 267 REMARK 465 THR A 268 REMARK 465 PRO A 269 REMARK 465 LEU A 270 REMARK 465 GLN A 271 REMARK 465 GLU A 272 REMARK 465 GLN A 273 REMARK 465 SER A 274 REMARK 465 TYR A 477 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 263 CG CD CE NZ REMARK 470 LYS A 275 CG CD CE NZ REMARK 470 LYS A 336 CG CD CE NZ REMARK 470 LYS A 358 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 335 -169.43 -127.67 REMARK 500 GLU A 460 64.53 -108.25 REMARK 500 LYS A 474 -75.03 -36.80 REMARK 500 ASP A 475 46.29 -90.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EWR A 501 DBREF1 7E0A A 202 477 UNP PPARG-1_HUMAN DBREF2 7E0A A P37231-1 230 505 SEQADV 7E0A GLY A 198 UNP P37231-1 EXPRESSION TAG SEQADV 7E0A SER A 199 UNP P37231-1 EXPRESSION TAG SEQADV 7E0A HIS A 200 UNP P37231-1 EXPRESSION TAG SEQADV 7E0A MET A 201 UNP P37231-1 EXPRESSION TAG SEQRES 1 A 280 GLY SER HIS MET ASP GLN LEU ASN PRO GLU SER ALA ASP SEQRES 2 A 280 LEU ARG ALA LEU ALA LYS HIS LEU TYR ASP SER TYR ILE SEQRES 3 A 280 LYS SER PHE PRO LEU THR LYS ALA LYS ALA ARG ALA ILE SEQRES 4 A 280 LEU THR GLY LYS THR THR ASP LYS SER PRO PHE VAL ILE SEQRES 5 A 280 TYR ASP MET ASN SER LEU MET MET GLY GLU ASP LYS ILE SEQRES 6 A 280 LYS PHE LYS HIS ILE THR PRO LEU GLN GLU GLN SER LYS SEQRES 7 A 280 GLU VAL ALA ILE ARG ILE PHE GLN GLY CYS GLN PHE ARG SEQRES 8 A 280 SER VAL GLU ALA VAL GLN GLU ILE THR GLU TYR ALA LYS SEQRES 9 A 280 SER ILE PRO GLY PHE VAL ASN LEU ASP LEU ASN ASP GLN SEQRES 10 A 280 VAL THR LEU LEU LYS TYR GLY VAL HIS GLU ILE ILE TYR SEQRES 11 A 280 THR MET LEU ALA SER LEU MET ASN LYS ASP GLY VAL LEU SEQRES 12 A 280 ILE SER GLU GLY GLN GLY PHE MET THR ARG GLU PHE LEU SEQRES 13 A 280 LYS SER LEU ARG LYS PRO PHE GLY ASP PHE MET GLU PRO SEQRES 14 A 280 LYS PHE GLU PHE ALA VAL LYS PHE ASN ALA LEU GLU LEU SEQRES 15 A 280 ASP ASP SER ASP LEU ALA ILE PHE ILE ALA VAL ILE ILE SEQRES 16 A 280 LEU SER GLY ASP ARG PRO GLY LEU LEU ASN VAL LYS PRO SEQRES 17 A 280 ILE GLU ASP ILE GLN ASP ASN LEU LEU GLN ALA LEU GLU SEQRES 18 A 280 LEU GLN LEU LYS LEU ASN HIS PRO GLU SER SER GLN LEU SEQRES 19 A 280 PHE ALA LYS LEU LEU GLN LYS MET THR ASP LEU ARG GLN SEQRES 20 A 280 ILE VAL THR GLU HIS VAL GLN LEU LEU GLN VAL ILE LYS SEQRES 21 A 280 LYS THR GLU THR ASP MET SER LEU HIS PRO LEU LEU GLN SEQRES 22 A 280 GLU ILE TYR LYS ASP LEU TYR HET EWR A 501 59 HETNAM EWR (2S)-2-ETHOXY-3-[4-[2-[2-METHYL-5-(4- HETNAM 2 EWR METHYLSULFANYLPHENYL)PYRROL-1- HETNAM 3 EWR YL]ETHOXY]PHENYL]PROPANOIC ACID FORMUL 2 EWR C25 H29 N O4 S FORMUL 3 HOH *87(H2 O) HELIX 1 AA1 ASN A 205 PHE A 226 1 22 HELIX 2 AA2 THR A 229 THR A 238 1 10 HELIX 3 AA3 ASP A 251 ILE A 262 1 12 HELIX 4 AA4 GLU A 276 SER A 302 1 27 HELIX 5 AA5 GLY A 305 LEU A 309 5 5 HELIX 6 AA6 ASP A 310 LEU A 333 1 24 HELIX 7 AA7 ARG A 350 SER A 355 1 6 HELIX 8 AA8 MET A 364 ALA A 376 1 13 HELIX 9 AA9 ASP A 380 LEU A 393 1 14 HELIX 10 AB1 ASN A 402 HIS A 425 1 24 HELIX 11 AB2 GLN A 430 GLU A 460 1 31 HELIX 12 AB3 HIS A 466 ASP A 475 1 10 SHEET 1 AA1 4 PHE A 247 ILE A 249 0 SHEET 2 AA1 4 GLY A 346 THR A 349 1 O PHE A 347 N ILE A 249 SHEET 3 AA1 4 GLY A 338 ILE A 341 -1 N VAL A 339 O MET A 348 SHEET 4 AA1 4 MET A 334 ASN A 335 -1 N ASN A 335 O GLY A 338 CISPEP 1 LYS A 358 PRO A 359 0 6.22 SITE 1 AC1 17 PHE A 264 HIS A 266 PHE A 282 GLY A 284 SITE 2 AC1 17 CYS A 285 ARG A 288 SER A 289 HIS A 323 SITE 3 AC1 17 TYR A 327 LEU A 333 LEU A 340 ILE A 341 SITE 4 AC1 17 SER A 342 MET A 364 HIS A 449 LEU A 469 SITE 5 AC1 17 TYR A 473 CRYST1 65.798 65.798 156.765 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015198 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015198 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006379 0.00000